A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rong Chen, Ph.D
Eucure (Beijing) Biopharma Co., Ltd
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gabrail Cancer Center Research
Canton, Ohio, Armenia
- University of New South Wales (unsw) - Liverpool Hospital
Liverpool, New South Wales, Australia
- Andrew Love Cancer Centre
Geelong, Victoria, Australia
- Coffs Harbour Health Campus
Coffs Harbour, New South Wales, Austria
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China
- the Affiliated Tumour Hospital of Harbin Medical University
Harbin, Heilongjiang, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- Hubei Cancer Hospital
Wuhan, Hubei, China
- Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
- Nantong Tumor Hospital
Nantong, Jiangsu, China
- Bethune First Hospital of Jilin University
Changchun, Jilin, China
- Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University
Chengdu, Sichuan, China
- Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
- Kaohsiung Medical University - Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
- China Medical University Hospital
Taichung, Taiwan
- Chi Mei Medical Center - Liouying
Tainan, Taiwan
- Chi Mei Medical Center - Yongkang
Tainan, Taiwan
- Taipei Medical University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2023
- Primary completion
- 31 Dec 2024
- Completion
- 31 Mar 2025
- Last update posted
- 20 Mar 2023
- Registered enrollment
- 0
- Registry id
- NCT05212922
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.